<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35168680</PMID><DateCompleted><Year>2022</Year><Month>02</Month><Day>17</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1752-1947</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Feb</Month><Day>15</Day></PubDate></JournalIssue><Title>Journal of medical case reports</Title><ISOAbbreviation>J Med Case Rep</ISOAbbreviation></Journal><ArticleTitle>Hyperbaric oxygen treatment for long coronavirus disease-19: a&#xa0;case report.</ArticleTitle><Pagination><StartPage>80</StartPage><MedlinePgn>80</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">80</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s13256-022-03287-w</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The coronavirus disease 2019 pandemic has resulted in a growing population of individuals who experience a wide range of persistent symptoms referred to as "long COVID." Symptoms include neurocognitive impairment and fatigue. Two potential mechanisms could be responsible for these long-term unremitting symptoms: hypercoagulability, which increases the risk of blood vessel occlusion, and an uncontrolled continuous inflammatory response. Currently, no known treatment is available for long COVID. One of the options to reverse hypoxia, reduce neuroinflammation, and induce neuroplasticity is hyperbaric oxygen therapy. In this article, we present the first case report of a previously healthy athletic individual who suffered from long COVID syndrome treated successfully with hyperbaric oxygen therapy.</AbstractText><AbstractText Label="CASE PRESENTATION" NlmCategory="METHODS">A previously healthy 55-year-old Caucasian man presented 3&#xa0;months after severe coronavirus disease 2019 infection with long COVID syndrome. His symptoms included a decline in memory, multitasking abilities, energy, breathing, and physical fitness. After evaluation that included brain perfusion magnetic resonance imaging, diffusion tensor imaging, computerized cognitive tests, and cardiopulmonary test, he was treated with hyperbaric oxygen therapy. Each session included exposure to 90&#xa0;minutes of 100% oxygen at 2 atmosphere absolute pressure with 5-minute air breaks every 20&#xa0;minutes for 60 sessions, 5&#xa0;days per week. Evaluation after completing the treatment showed significant improvements in brain perfusion and microstructure by magnetic resonance imaging and significant improvement in memory with the most dominant effect being on nonverbal memory, executive functions, attention, information procession speed, cognitive flexibility, and multitasking. The improved cognitive functions correlated with the increased cerebral blood flow in brain regions as measured by perfusion magnetic resonance imaging. With regard to physical capacity, there was a 34% increase in the maximum rate of oxygen consumed during exercise and a 44% improvement in forced vital capacity. The improved physical measurements correlated with the regain of his pre-COVID physical capacity.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We report the first case of successfully treated long COVID symptoms with hyperbaric oxygen therapy with improvements in cognition and cardiopulmonary function. The beneficial effects of hyperbaric oxygen shed additional light on the pathophysiology of long COVID. As this is a single case report, further prospective randomized control studies are needed.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bhaiyat</LastName><ForeName>Aisha M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Aviv Clinics, Jumeirah Lake Towers, Dubai, United Arab Emirates. aisha@aviv-clinics.ae.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sasson</LastName><ForeName>Efrat</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Aviv Scientific Ltd, 7 Mezada Street, Bnei Brak, Israel.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Zemer</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Aviv Clinics, Jumeirah Lake Towers, Dubai, United Arab Emirates.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khairy</LastName><ForeName>Sherif</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Aviv Clinics, Jumeirah Lake Towers, Dubai, United Arab Emirates.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ginzarly</LastName><ForeName>Mouzayan</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Aviv Clinics, Jumeirah Lake Towers, Dubai, United Arab Emirates.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qureshi</LastName><ForeName>Umair</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Aviv Clinics, Jumeirah Lake Towers, Dubai, United Arab Emirates.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fikree</LastName><ForeName>Moin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Rashid Hospital Trauma Center, Dubai, United Arab Emirates.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Efrati</LastName><ForeName>Shai</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Sagol Center for Hyperbaric Medicine and Research, Shamir Medical Center, Israel Sackler School of Medicine and Sagol School of Neuroscience, Tel-Aviv University, Tel Aviv, Israel. efratishai@outlook.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>02</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>J Med Case Rep</MedlineTA><NlmUniqueID>101293382</NlmUniqueID><ISSNLinking>1752-1947</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>S88TT14065</RegistryNumber><NameOfSubstance UI="D010100">Oxygen</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056324" MajorTopicYN="N">Diffusion Tensor Imaging</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006931" MajorTopicYN="Y">Hyperbaric Oxygenation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010100" MajorTopicYN="N">Oxygen</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Case report</Keyword><Keyword MajorTopicYN="N">HBOT</Keyword><Keyword MajorTopicYN="N">Hyperbaric oxygen therapy</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>AMB, ZW, SK, MG, and UQ work for AVIV Clinics. ES works for AVIV Scientific LTD. SE is a co-founder and shareholder at AVIV Scientific LTD.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>10</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>1</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>2</Month><Day>16</Day><Hour>5</Hour><Minute>35</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>2</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>2</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35168680</ArticleId><ArticleId IdType="pmc">PMC8848789</ArticleId><ArticleId IdType="doi">10.1186/s13256-022-03287-w</ArticleId><ArticleId IdType="pii">10.1186/s13256-022-03287-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lopez-Leon S, et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11(1):16144. doi: 10.1038/s41598-021-95565-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95565-8</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Levi M, et al. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol. 2020;7(6):e438&#x2013;e440. doi: 10.1016/S2352-3026(20)30145-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-3026(20)30145-9</ArticleId><ArticleId IdType="pmc">PMC7213964</ArticleId><ArticleId IdType="pubmed">32407672</ArticleId></ArticleIdList></Reference><Reference><Citation>Mahmudpour M, et al. COVID-19 cytokine storm: the anger of inflammation. Cytokine. 2020;133:155151. doi: 10.1016/j.cyto.2020.155151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cyto.2020.155151</ArticleId><ArticleId IdType="pmc">PMC7260598</ArticleId><ArticleId IdType="pubmed">32544563</ArticleId></ArticleIdList></Reference><Reference><Citation>Li B, et al. Brain&#x2013;immune interactions in perinatal hypoxic-ischemic brain injury. Prog Neurobiol. 2017;159:50&#x2013;68. doi: 10.1016/j.pneurobio.2017.10.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2017.10.006</ArticleId><ArticleId IdType="pmc">PMC5831511</ArticleId><ArticleId IdType="pubmed">29111451</ArticleId></ArticleIdList></Reference><Reference><Citation>Shapira R, et al. Hyperbaric oxygen therapy ameliorates pathophysiology of 3xTg-AD mouse model by attenuating neuroinflammation. Neurobiol Aging. 2018;62:105&#x2013;119. doi: 10.1016/j.neurobiolaging.2017.10.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2017.10.007</ArticleId><ArticleId IdType="pubmed">29141186</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L, et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet. 2021;398(10302):747&#x2013;758. doi: 10.1016/S0140-6736(21)01755-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)01755-4</ArticleId><ArticleId IdType="pmc">PMC8389999</ArticleId><ArticleId IdType="pubmed">34454673</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadanny A, Efrati S. Oxygen&#x2014;a limiting factor for brain recovery. Crit Care. 2015;19:307. doi: 10.1186/s13054-015-1034-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-015-1034-2</ArticleId><ArticleId IdType="pmc">PMC4556415</ArticleId><ArticleId IdType="pubmed">26329929</ArticleId></ArticleIdList></Reference><Reference><Citation>Katsoularis I, et al. Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study. Lancet. 2021;398(10300):599&#x2013;607. doi: 10.1016/S0140-6736(21)00896-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00896-5</ArticleId><ArticleId IdType="pmc">PMC8321431</ArticleId><ArticleId IdType="pubmed">34332652</ArticleId></ArticleIdList></Reference><Reference><Citation>Pena-Villalobos I, et al. Hyperbaric oxygen increases stem cell proliferation, angiogenesis and wound-healing ability of WJ-MSCs in diabetic mice. Front Physiol. 2018;9:995. doi: 10.3389/fphys.2018.00995.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphys.2018.00995</ArticleId><ArticleId IdType="pmc">PMC6078002</ArticleId><ArticleId IdType="pubmed">30104981</ArticleId></ArticleIdList></Reference><Reference><Citation>Cabigas BP, et al. Hyperoxic and hyperbaric-induced cardioprotection: role of nitric oxide synthase 3. Cardiovasc Res. 2006;72(1):143&#x2013;151. doi: 10.1016/j.cardiores.2006.06.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cardiores.2006.06.031</ArticleId><ArticleId IdType="pubmed">16930572</ArticleId></ArticleIdList></Reference><Reference><Citation>Gregorevic P, Lynch GS, Williams DA. Hyperbaric oxygen modulates antioxidant enzyme activity in rat skeletal muscles. Eur J Appl Physiol. 2001;86(1):24&#x2013;27. doi: 10.1007/s004210100503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s004210100503</ArticleId><ArticleId IdType="pubmed">11820317</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Z, et al. Protection of mitochondrial function and improvement in cognitive recovery in rats treated with hyperbaric oxygen following lateral fluid-percussion injury. J Neurosurg. 2007;106(4):687&#x2013;694. doi: 10.3171/jns.2007.106.4.687.</Citation><ArticleIdList><ArticleId IdType="doi">10.3171/jns.2007.106.4.687</ArticleId><ArticleId IdType="pubmed">17432723</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadanny A, et al. Hyperbaric oxygen therapy improves neurocognitive functions of post-stroke patients&#x2014;a retrospective analysis. Restor Neurol Neurosci. 2020;38(1):93&#x2013;107.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7081098</ArticleId><ArticleId IdType="pubmed">31985478</ArticleId></ArticleIdList></Reference><Reference><Citation>Horie M, et al. Enhancement of satellite cell differentiation and functional recovery in injured skeletal muscle by hyperbaric oxygen treatment. J Appl Physiol. 2014;116(2):149&#x2013;155. doi: 10.1152/japplphysiol.00235.2013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/japplphysiol.00235.2013</ArticleId><ArticleId IdType="pubmed">24336879</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadanny A, et al. Hyperbaric oxygen therapy effects on pulmonary functions: a prospective cohort study. BMC Pulm Med. 2019;19(1):148. doi: 10.1186/s12890-019-0893-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12890-019-0893-8</ArticleId><ArticleId IdType="pmc">PMC6693142</ArticleId><ArticleId IdType="pubmed">31409407</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>